Cancer Research · 2018 · 41 citations · 42 references
MedicineMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCell Signaling DisruptionColorectal CancerMetastatic Signaling PathwaysOncogenic Signaling PathwaysSignal Transduction In CancerBeta-catenin RegulationCancer Signaling PathwaysErk SignalingExtracellular Signal-regulated Kinase PathwayMapk SignalingMek InhibitionMek InhibitorsScaffold Protein Signaling
Abstract MAPK signaling pathways are constitutively active in colon cancer and also promote acquired resistance to MEK1 inhibition. Here, we demonstrate that BRAFV600E-mutated colorectal cancers acquire resistance to MEK1 inhibition by inducing expression of the scaffold protein CEMIP through a β-catenin– and FRA-1–dependent pathway. CEMIP was found in endosomes and bound MEK1 to sustain ERK1/2 activation in MEK1 inhibitor–resistant BRAFV600E-mutated colorectal cancers. The CEMIP-dependent pathway maintained c-Myc protein levels through ERK1/2 and provided metabolic advantage in resistant cells, potentially by sustaining amino acids synthesis. CEMIP silencing circumvented resistance to MEK1 inhibition, partly, through a decrease of both ERK1/2 signaling and c-Myc. Together, our data identify a cross-talk between Wnt and MAPK signaling cascades, which involves CEMIP. Activation of this pathway promotes survival by potentially regulating levels of specific amino acids via a Myc-associated cascade. Targeting this node may provide a promising avenue for treatment of colon cancers that have acquired resistance to targeted therapies. Significance: MEK1 inhibitor–resistant colorectal cancer relies on the scaffold and endosomal protein CEMIP to maintain ERK1/2 signaling and Myc-driven transcription. Cancer Res; 78(16); 4533–48. ©2018 AACR.
42
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
MetaboAnalyst 3.0—making metabolomics more meaningful
Jianguo Xia, Igor Sinelnikov, David S. Wishart · Nucleic Acids Research · 2015 · 2.7K citations · Full text
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad, Chong Sun, Sidong Huang et al. · Nature · 2012 · 2.1K citations · Full text
Medicine, Cancer Biology, Oncology +14